IMPPP-Studie
IMPPP - Improving Medicines use in People with Polypharmacy in Primary Care
Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP) ist ein vom National Institute of Health Research (NIHR) gefördertes Projekt, das zum Ziel hat, eine auf dem P-DQIP Ansatz beruhende Intervention im Rahmen einer multizentrischen cluster-randomisierten Studie im Kontext des Englischen National Health Service (NHS) zu evaluieren. Erste Ergebnisse werden voraussichtlich Ende 2020 vorliegen.
- Payne RA, Blair PS, Caddick B, Chew-Graham CA, Dreischulte T, Duncan LJ, Guthrie B, Mann C, Parslow RM, Round J, Salisbury C, Turner KM, Turner NL, McCahon D. Optimising polypharmacy management in primary care through general practitioner-pharmacist collaboration, informatics, and enhancing clinician engagement: the IMPPP cluster-randomised trial. Lancet Healthy Longev. 2025 Oct;6(10):100774. doi: 10.1016/j.lanhl.2025.100774.
- Parslow RM, Duncan LJ, Caddick B, Chew-Graham CA, Turner K, Payne RA, Man C, Guthrie B, Blair PS, McCahon D. Collaborative discussions between GPs and pharmacists to optimise patient medication: a qualitative study within a UK primary care clinical trial. Br J Gen Pract. 2024 Oct 31;74(748):e727-e734. doi: 10.3399/BJGP.2024.0190.
- Payne RA, Blair PS, Caddick B, Chew-Graham CA, Dreischulte T, Duncan LJ, Guthrie B, Mann C, Parslow RM, Round J, Salisbury C, Turner KM, Turner NL, McCahon D. Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP): Protocol for a multicentre cluster randomised trial comparing a complex intervention for medication optimization against usual care. NIHR Open Res. 2022 Nov 8;2:54. doi: 10.3310/nihropenres.13285.1.
